Publications and Presentations

SCIENTIFIC OUTCOMES

Health Analytics' scientific team regularly contributes articles to trade and peer-reviewed publications. Our publications and presentations are just some examples of the many  pertinent resources our company provides for clients, peers, and the healthcare community.


JOURNAL PUBLICATIONS

Tkacz, J.P., Ellis, L., Bolge, S., Meyer, R., Brady, B., & Ruetsch, C.  (2014).  Utilization and Adherence Patterns Associated with Subcutaneously Administered Anti-TNF Treatment Among Rheumatoid Arthritis Patients: An Analysis of Medical and Pharmacy Claims. Clinical Therapeutics, accepted for publication.

Tkacz, J.P., Lofland, J., Vanderpoel, J., Kardel, P., & Ruetsch, C.  (2014).  Infliximab dosing patterns among a sample of Crohn’s disease patients: Results from an integrated medical chart review. American Health and Drug Benefits, accepted for publication.

Tkacz, J., Pesa, J., Vo, L., Kardel, P., Un, H., Volpicelli, J., Ruetsch, C. Opioid Analgesic–Treated Chronic Pain Patients at Risk for Problematic Use. American Journal of Managed Care, 19(11):871-880; 2013

Ruetsch, C., Tkacz, J., Kardel, P., Howe, A., Pai, H., & Levitan, B. Trajectories of health care service utilization and differences in patient characteristics among adults with specific chronic pain: analysis of health plan member claims. Journal Of Pain Research, 6, 137-149; 2013

Ruetsch, C., Tkacz, J., McPherson, T., & Cacciola, J. The effect of telephonic patient support on treatment for opioid dependence: Outcomes at one year follow-up. Addictive Behaviors, 37(5), 686-689; 2012

Tkacz, J., Severt, J., Kassed, C., & Ruetsch, C. Clinical Differences Between Opioid Abuse Classes Ameliorated After 1 Year of Buprenorphine-Medication Assisted Treatment. Journal Of Addictive Diseases, 31(2), 100-111; 2012

Tkacz, J. P., Severt, J., Ruetsch, C. Opioid relapse rates among a sample of new buprenorphine-medication assisted treatment patients: Relationship to compliance at one year follow-up.  American Journal on Addictions, 21(1), 55-62; 2012 

Tkacz J. P., Hobbs, S. H., & Elkins, R. L. The GABA antagonist picrotoxin attenuates an ethanol-induced taste aversion in taste aversion-prone rats.  Neuroscience & Medicine, 2(4), 363-369; 2011

 Ruetsch, C., Tkacz, J. P., Dewan, N.  Improving quality and accountability through information systems.  In Dewan, N., Luo, J., & Lorenzi, N. (Eds.), Information technology essentials for behavioral health clinicians.  New York: Springer; 2011   

Ruetsch, C., Cacciola, J., Tkacz, J.P.  A National Study of a Telephone Survey Support Service of Patients Receiving Office-Based Buprenorphine-Medication Assisted Treatment: Study Feasibility and Sample Description Journal of Substance Abuse Treatment, 39(4), 307-317; 2010

Jan, S., Ruetsch, C., Nicholls, L., Bragaw, L.  Opioid Dependence: Managing the High Cost of Treatment Failure. Featured articles: Empirical View of Opioid Dependence; Opioid Dependence Treatment and Guidelines; Practice Strategies to Improve Compliance and Patient Self-Management. Supplement to Journal of Managed Care Physicians Vol. 16, No. 1-b; 2010

Albright, J., Ciaverelli, R., Essex, A., Tkacz, J.P., Ruetsch, C.  Psychiatrists Characteristics That Influence the Use of Buprenorphine-Medication Assisted TreatmentJournal of Addiction Medicine, 4(4), 197-203; December 2010

Ruetsch, C.  Opioid Dependence, the Criminal Justice System, and Buprenorphine-Medication Assisted Therapy. All Rise, Vol. 1, No. 1; 2009

 

CONFERENCE PRESENTATIONS

ISPOR 2013

 Ruetsch C, Tkacz, J (2013). Comparison of two Methods for Identifying Problematic Opioid Use Among an Opioid-Treated Chronic Pain Population. International Society for Pharmacoeconomic and Outcomes Research 2013, May 18-22. New Orleans, LA.

Ruetsch C, Tkacz J, Kardel P, Wong, W (2013). Methodology for Incorporating Medical Chart Data Into an Administrative Claims Database: an Analysis of Biologic Treatment in a Sample of Crohn's Disease Patients. International Society for Pharmacoeconomic and Outcomes Research 2013, May 18-22. New Orleans, LA.

Pain Week 2012

Tkacz, J.P, Kardel, P., Pesa, J., Un, H, Volpicelli, J., & Ruetsch, C. (2012). Problematic opioid use and opioid addiction amongst Aetna’s opioid analgesic treated chronic pain population: An analysis of healthcare service utilization and costs. Pain Week, September 5-8, Las Vegas, NV.

Pesa, J., Un, H., Kardel, P., Tkacz, J.P, Volpicelli, J., & Ruetsch, C. (2012). Rate of Cross-Over to Problematic Opioid Use and Associated Costs Among Opioid Analgesic-Treated Chronic (Non-Cancer) Pain Patients Within a Commercially Insured Population. Pain Week, September 5-8, Las Vegas, NV.

AMCP 2012

Bolge, S.C.,Tkacz, J.P., Kassed, C.A., Ruetsch, C., Ingham, M.P., & Wong, W. (2012). Dosing patterns of infliximab in Rheumatoid Arthritis patients enrolled in a mid-atlantic commercial health plan. Abstract accepted at the Academy of Managed Care Pharmacy’s 2012 Spring Conference, April 18-20th, San Francisco, CA.

Crohn’s and Colitis Foundation

Lofland, J.H., Vanderpoel, J., Kassed, C.A., Tkacz, J., Nicholls, L., Ruetsch, C. (2011). Stability of infliximab dosing among individuals with Crohn’s Disease: Results from a Mid-Atlantic health plan. Poster presented at the 2011 Crohn’s and Colitis Foundation’s Clinical and Research Conference, December 1-3, 2011, Hollywood, FL.

 Vanderpoel, J., Lofland, J.H., Bolge, S.C., Schenkel, B., Mody, C., Kassed, C., Tkacz, J., Nicholls, L., Tanner, J. (2011). Infliximab utilization patterns within an alternate site of care setting among patients with inflammatory bowel disease. Poster presented at the 2011 Crohn’s and Colitis Foundation’s Clinical and Research Conference, December 1-3, 2011, Hollywood, FL. 

ISPOR - EU 2011

Severt, J., Tkacz, J.P., & Ruetsch, C. (2011). Differences between opioid dependent patients in Italy and Germany receiving substitution therapy. Poster presented at the International Society for Pharmacoeconomic and Outcomes Research 14th Annual European Meeting, November 5-8, Madrid, Spain.

Severt, J., Tkacz, J.P., & Ruetsch, C. (2011). Physician differences between Italy and Germany: The treatment of opioid dependence substitution therapy. Poster presented at the International Society for Pharmacoeconomic and Outcomes Research 14th Annual European Meeting, November 5-8, Madrid, Spain.

ACG

Schmeichel, C., Denny, L, Tkacz, J. P., Ruetsch, C. (2011). Infliximab infusion patterns in patients with Crohn’s disease naive to biologic therapy: An analysis of a national health plan. Poster presented at the American College of Gastroenterology Annual Meeting, Oct 18th – Nov 2, 2011, Washington, DC. 

AATOD 2010

Ruetsch, C., Tkacz, J.P. The Effect af a Telephonic Patient Support Program on Treatment for Opioid Dependence: Outcomes at One Year. Poster presented at the American Association of the Treatment of Opioid Dependence, Oct. 23-27, 2010, Chicago, IL.

Ruetsch, C., Tkacz, J.P. A Longitudinal Analysis of the Effect of Buprenorphine-Medication Assisted Treatment (B-MAT) and a Structured Patient Support Program on B-MAT Adherence for the Treatment of Opioid Dependence. Poster presented at the American Association of the Treatment of Opioid Dependence, Oct. 23-27, 2010, Chicago, IL.

Ruetsch, C., Tkacz, J.P. Refusal of Ancillary Support Services Early in Opioid Dependence Treatment Predicts Six Month Buprenorphine-Medication Assisted Treatment Compliance. Poster presented at the American Association of the Treatment of Opioid Dependence, Oct. 23-27, 2010, Chicago, IL.

Ruetsch, C., Tkacz, J.P. Opioid Relapse Rates Among a Sample of New Buprenorphine-Medication Assisted Treatment Patients: Relationship with Medication Compliance at One Year. Poster presented at the American Association of the Treatment of Opioid Dependence, Oct. 23-27, 2010, Chicago, IL.

NIATx/SAAS 2010

Ruetsch, C. Improving Outcomes and Reducing Costs in the Treatment of Opioid Dependence. Podium presentation at the NIATx/SAAS, July 12-23, 2010, Cincinnati, OH.

NIDA 2010

Ruetsch, C., Tkacz, J.P. Recruiting Opioid Dependent Patients Seeking Treatment in Office-based Settings: Methodology and Comparison to Normative Sample: One Year Follow-up. Poster presented at the National Institute on Drug Abuse: Blending Conference, April 22-23, 2010, Albuquerque, NM.

Ruetsch, C., Tkacz, J.P. Telephonic Compliance Enhancement Program for Patients Receiving Burprenorphine-Medication Assisted Therapy: Results at One Year. Poster presented at the National Institute on Drug Abuse: Blending Conference, April 22-23, 2010, Albuquerque, NM.

AAAP 2009

Ruetsch, C., Tkacz, J.P. Drug Use Severity Predicts Subsequent Buprenorphine-Replacement Treatment Compliance and Drug Use Behavior Among Opioid Dependence Patients. Poster presented at the American Academy of Addiction Psychiatry: 20th Annual Meeting & Symposium, Dec. 3-6, 2009, Los Angeles, CA.

Ruetsch, C., Tkacz, J.P. Differences in Opioid Dependence Severity by Health Insurance Ameliorated by Month Three of Buprenorphine Treatment. Poster presented at the American Academy of Addiction Psychiatry: 20th Annual Meeting & Symposium, Dec. 3-6, 2009, Los Angeles, CA.

Tkacz, J.P., Ruetsch, C. Compliance with Buprenorphine-Medication Assisted Therapy Decreases Drug Use Among Opiate Addicts: A Randomized Controlled Trial. Poster presented at the American Academy of Addiction Psychiatry: 20th Annual Meeting & Symposium, Dec. 3-6, 2009, Los Angeles, CA.

Ruetsch, C., Tkacz, J.P. Buprenorphine-Medication Assisted Therapy: A Full Economic Analysis of Health Plan Data. Poster presented at the American Academy of Addiction Psychiatry: 20th Annual Meeting & Symposium, Dec. 3-6, 2009, Los Angeles, CA.

NAMCP Fall 2009

Ruetsch, C. Comparative Effectiveness Research: An Illustrative Example with Opioid Dependence. CME Presentation at the NAMCP/AAIHDS/AAMCN Fall Managed Care Forum, Nov. 12-13, 2009, Las Vegas, NV

AMCP 2009

Ruetsch, C., Tkacz, J.P., Schoenberger, C.A. Opioid Dependence Treatment Outcomes Improve with Addition of Structured Patient Support Program. Poster presented at the Academy of Managed Care Pharmacy: Educational Conference, Oct. 7-10, 2009, San Antonio, TX

Ruetsch, C., Schoenberger, C.A., Tkacz, J.P. Cost-Effectiveness of Medication-Replacement Therapy with Buprenorphine Among Opioid Dependent Patients: Results From a Retrospective Analysis of Health Plan Membership Claims Data. Poster presented at the Academy of Managed Care Pharmacy: Educational Conference, Oct. 7-10, 2009, San Antonio, TX

ISPOR Fall 2009

Ruetsch, C., Schoenberger, C.A. Factors That Predict Early Treatment Failure Among Patients in Outpatient Treatment for Opioid Dependence. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research: 2nd Latin Conference, Sept. 10-12, 2009, Rio De Janeiro, Brazil

Ruetsch, C., Schoenberger, C.A. Methods for Achieving and Maintaining Adequate Study Subject Participation for a Multi-Site Time Series Trial. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research: 2nd Latin Conference, Sept. 10-12, 2009, Rio De Janeiro, Brazil

NIATx/SAAS 2009

Ruetsch, C. Here to Help Program Evaluation Study Preliminary Results. CME Presentation at the NIATx/SAAS Summit National Conference, July 29-Aug. 1, 2009, Tucson, AZ

NADCP 2009

Ruestch, C., Pick, C. Advances in Medication Assisted Treatment For Opioid Dependence. CME Presentation at the National Association of Drug Court Professionals: 15th Annual Drug Court Training, June 8-11, 2009, Anaheim, CA

ISPOR Spring 2009

Ruetsch, C., Schoenberger, C.A., Tkacz, J.P. Factors That Influence Decisions Among MBHO Network Physicians to Use Office Based Treatment or Opioid Dependence or to Increase Numbers of Opioid Dependent Patients They Treat: Results and Psychometric Evaluation of the OBOT Attitude and Intention Physician Survey. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research: 14th Annual International Meeting, May 16-20, 2009, Orlando, FL

Ruetsch, C., Schoenberger, C.A., Tkacz, J.P. Methods for Optimizing Subject Recruitment and Retention Through Private Practice Offices. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research: 14th Annual International Meeting, May 16-20, 2009, Orlando, FL

Ruetsch, C. Opioid Dependence: Managing the High Cost of Treatment Failure. CME Presentation at the Academy of Managed Care Pharmacy 21st Annual Meeting, April 15-18, 2009, Orlando, FL

  

Charles Ruetsch, Ph.D. was quoted in the March 2010 issue of Managed Healthcare Executive: 

 "Changes in healthcare policy have enormous implications for population health. Improvements might not happen as quickly as we would like, but it's important that those changes that we do make are backed by solid clinincal and scientific data. People's lives are at stake."
          

 View Entire Article